DexCom, Inc. vs PubMatic Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while PubMatic Inc trades at $17.52 (market cap $804.41M). The key difference: DexCom, Inc. is far larger — about 42× PubMatic Inc's market cap. Which is the better fit depends on your goals.
| DXCM | PUBM | |
|---|---|---|
Market Cap | $33.79B | $804.41M |
Sector | Health | Technology |
52-Week High | $89.53 | $17.78 |
52-Week Low | $54.84 | $6.28 |
Enterprise Value | $33.24B | $707.54M |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →